Austin, TX, United States of America

Michael A Sandoval

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Austin, TX (US) (2017 - 2022)
  • Chicago, IL (US) (2019 - 2023)
  • Beaverton, OR (US) (2021 - 2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Michael A. Sandoval: Pioneering Drug Formulations

Introduction

Michael A. Sandoval is a prominent inventor based in Austin, TX, recognized for his significant contributions to the field of pharmaceutical formulations. With a total of six patents to his name, Sandoval has made substantial advancements in ensuring the effective delivery of therapeutic agents.

Latest Patents

Among his notable inventions is a patent focused on precipitation-resistant small molecule drug formulations. This innovative solution addresses the challenges posed by small molecule precipitation at the injection site, particularly when administering highly-concentrated formulations such as diazepam. The formulation incorporates a surfactant in a non-aqueous medium, enhancing the bioavailability of the drug by improving its absorption into systemic circulation.

Additionally, Sandoval holds a patent for producing stable therapeutic glucagon formulations in aprotic polar solvents. This invention outlines a method for creating a therapeutic agent formulation that includes at least one therapeutic agent dissolved in an aprotic polar solvent system. This system utilizes ionization stabilizing excipients that enhance the physical and chemical stability of the therapeutic agent, increasing its efficacy.

Career Highlights

Throughout his career, Michael A. Sandoval has made meaningful impacts in the pharmaceutical industry. He has worked with notable companies such as Xeris Pharmaceuticals, Inc., where he likely contributed to the development of innovative drug delivery systems. Additionally, his tenure at Disruption Labs, Inc. has empowered him to engage in cutting-edge research in pharmacology.

Collaborations

Sandoval has collaborated with esteemed professionals in his field, including Steven J. Prestrelski and Martin J. Donovan. These collaborations have enriched his research endeavors and brought forth a range of pharmaceutical innovations.

Conclusion

Michael A. Sandoval exemplifies the spirit of innovation in the pharmaceutical industry through his groundbreaking inventions and formulations. His work continues to advance the field, ensuring better therapeutic outcomes for patients, and highlighting the importance of collaboration among scientists and inventors in creating impactful solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…